Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact
Go back to Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact| PANDORA MEDIA, Inc. (NYSE: P) | Delayed: 8.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.38 | 52 Week High | $16.23 | |||
| Open | $0.00 | 52 Week Low | $7.10 | |||
| Day High | $8.38 | P/E | N/A | |||
| Day Low | $8.38 | EPS | $-0.15 | |||
| Volume | 209,100 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.05 +0.44 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.61 | 52 Week High | $37.39 | |||
| Open | $26.54 | 52 Week Low | $28.25 | |||
| Day High | $27.13 | P/E | 16.39 | |||
| Day Low | $26.23 | EPS | $1.65 | |||
| Volume | 53,162,645 | |||||
